Our founder, Dr. Joanne Weidhaas will be giving her first “TED talk” as an invited speaker at TEDxCulverCity on March 31, 2020! Joanne is a radiation oncologist and cancer researcher, and she…
Read More ➝
We want to start with the basics about Hormone Replacement Therapy, so you can get up to speed on the importance of MiraKind’s new study. In this article, we’ll cover what Hormone…
Read More ➝
MiraKind is committed to providing our community with the best tools possible to tackle challenges in the arena of women’s health. This is why MiraKind is partnering with gennev, a first-of-its-kind telehealth…
Read More ➝
When our team came across a recent Los Angeles Times Article entitled, “Once and for all: Hormone replacement is good for women” we were very intrigued. What we learned from this game-changing…
Read More ➝
A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal…
Read More ➝
We had an excellent question from a MiraKind study participant. They wanted to know, “If I participate in a study will you send me my KRAS-variant results?” Unfortunately, the answer is no….
Read More ➝
We received a great question from a friend of a patient asking, “since she knows she has a BRCA mutation, is it necessary to find out if she also has the KRAS-variant?…
Read More ➝
We had an excellent question from a participant who has the KRAS-variant and had chosen to have her ovaries removed. She asked her OB/GYN if she still needed to have pelvic exams…
Read More ➝
As discussed in our previous Genetics series posts, the discovery of non-coding RNAs paved the way for changes in the Central Dogma and how we think about the flow of genetic information…
Read More ➝
Webinar – KRAS-Variant and Breast Cancer Did you miss our live webinar on the KRAS-Variant with Dr. Joanne Weidhaas? Watch the replay and learn about how this genetic mutation can impact your…
Read More ➝
Menopause: a condition that 100% of women will experience, yet so few of us feel comfortable talking about. Let’s start with Perimenopause… Did you know that women in their 40s (and some…
Read More ➝
The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we have spoken a…
Read More ➝
Here at MiraKind, we’re constantly inspired by the amazing women who surround us; whether it is scientists and doctors working on our research, or the strong and empowered women who are facing complex health challenges with dignity and grace.
Read More ➝
While there are many factors to consider before taking hormone replacement therapy (HRT), understanding your genetic profile can prove invaluable in your decision-making process. Joanne Weidhaas, MD, PhD, and her colleagues published…
Read More ➝
This time of year, the malls and online stores are filled with shoppers, eager to purchase the perfect gift for friends and loved ones near and far. We may be biased, but…
Read More ➝
Disclaimer
Any discussion of medical management options on this website is for general informational purposes only and does not constitute a medical recommendation. All medical management decisions should be made based on consultation between each patient and his or her healthcare professional.
